TAK(Takeda Pharmaceutical Company Limited) · 财务报表

TAK(Takeda Pharmaceutical Company Limited) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-03-31FY 截至 2022-03-31FY 截至 2023-03-31FY 截至 2024-03-31FY 截至 2025-03-31
营业收入$30.15B$31.17B$29.61B$28.91B$30.32B
毛利润$20.77B$21.50B$20.46B$19.23B$19.87B
营业利润$4.80B$4.02B$3.61B$1.45B$2.27B
净利润$3.54B$2.01B$2.33B$976.74M$714.35M
经营现金流$9.53B$9.81B$7.18B$4.86B$7.00B
自由现金流$8.48B$8.73B$6.15B$3.67B$5.67B
摊薄每股收益$2.25$1.27$1.48$0.62$0.44

Takeda Pharmaceutical Company Limited TAK